MORE►
MarketWatch
David Halbert, founder, chairman, and CEO of Caris Life Sciences. [Courtesy: Caris]
Caris Life Sciences Debuts on Nasdaq With $7.66B Valuation
by Quincy Preston and David Seeley | Jun 18, 2025
The North Texas-based precision oncology firm raised $494 million in its IPO. Founder David Halbert is now a newly minted biotech billionaire worth an estimated $3.3 billion, Forbes reports.
